statistiche ricercatore

Continente	#
NA - Nord America	949
AS - Asia	485
EU - Europa	317
SA - Sud America	71
Continente sconosciuto - Info sul continente non disponibili	32
AF - Africa	21
OC - Oceania	4
Totale	1.879

Nazione	#
US - Stati Uniti d'America	892
SG - Singapore	159
IT - Italia	134
CN - Cina	87
VN - Vietnam	67
BD - Bangladesh	59
BR - Brasile	56
GB - Regno Unito	36
DE - Germania	35
HK - Hong Kong	34
CA - Canada	24
IN - India	19
FI - Finlandia	17
MX - Messico	12
NL - Olanda	12
SE - Svezia	12
FR - Francia	11
JP - Giappone	11
PL - Polonia	10
RU - Federazione Russa	10
ID - Indonesia	9
CR - Costa Rica	8
ES - Italia	7
IQ - Iraq	7
PK - Pakistan	7
ZA - Sudafrica	7
AT - Austria	6
TR - Turchia	6
EC - Ecuador	5
TT - Trinidad e Tobago	5
UA - Ucraina	5
VE - Venezuela	5
EG - Egitto	4
LT - Lituania	4
MA - Marocco	4
CZ - Repubblica Ceca	3
DK - Danimarca	3
KG - Kirghizistan	3
TN - Tunisia	3
AE - Emirati Arabi Uniti	2
AL - Albania	2
AR - Argentina	2
AU - Australia	2
BE - Belgio	2
CO - Colombia	2
CW - ???statistics.table.value.countryCode.CW???	2
EE - Estonia	2
GT - Guatemala	2
HU - Ungheria	2
KZ - Kazakistan	2
MY - Malesia	2
PH - Filippine	2
SV - El Salvador	2
TV - Tuvalu	2
AM - Armenia	1
AO - Angola	1
BG - Bulgaria	1
BH - Bahrain	1
BS - Bahamas	1
CL - Cile	1
DZ - Algeria	1
GR - Grecia	1
HN - Honduras	1
JO - Giordania	1
LK - Sri Lanka	1
ML - Mali	1
MN - Mongolia	1
NI - Nicaragua	1
NO - Norvegia	1
OM - Oman	1
PR - Porto Rico	1
SA - Arabia Saudita	1
SI - Slovenia	1
SY - Repubblica araba siriana	1
UZ - Uzbekistan	1
Totale	1.849

Nome	#
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?	278
Estrogen receptor mutation: a new strategy to overcome endocrine resistance	234
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma	230
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach	194
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study	191
Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities?	173
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives	166
Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer	159
The Role of Radiomics and Artificial Intelligence Applied to Staging PSMA PET in Assessing Prostate Cancer Aggressiveness	142
The Value of FDG PET/CT in Penile Cancer: An Update	62
Diagnostic accuracy of 18F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study	50
Totale	1.879

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	19	0	0	0	0	1	2	0	1	4	2	4	5
2022/2023	68	2	4	7	7	12	9	9	10	5	0	3	0
2023/2024	63	3	6	2	2	1	16	2	8	6	0	2	15
2024/2025	239	8	6	18	19	20	18	10	13	32	19	28	48
2025/2026	1.172	98	35	129	146	144	60	124	49	101	126	97	63
2026/2027	271	42	42	91	96	0	0	0	0	0	0	0	0
Totale													1.879

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara